Get access to curated patient data for a specific sub population to guide go/ no-go decisions, inform study design, and develop ECAs to support regulatory submission.
Our Focus product is a highly customized, enriched real-world patient data package designed to support your specific research objectives.
Focus data can be tailored to specific patient cohorts to support ancilliary approval submissions for small populations.
Conduct Phase IV and HEOR studies to identify patterns in treatment response for specific patient sub cohorts.
COTA’s database of patients includes longitudinal treatment and outcomes data for oncology patients including:
Real-World Insights and Support is an optional add-on that pairs perfectly with your Focus data. Our team of clinical experts, researchers, and statisticians will come alongside your teams to help them use the data to design studies, run analyses, and construct regulatory submission packages.
Explore our collection of clinical research, recent press, podcasts, and more.
Cancer is an insidious disease. Even after surgery or aggressive systemic therapy, malignant cells often take refuge in hard-to-identify places...
The FDA plays an incredibly important role in the process of developing, distributing, and monitoring therapeutic products. So when something...
Real-world data (RWD) from electronic health records (EHRs) is increasingly recognized as a powerful asset for oncology research. It enables...
Discover the power of real-world cancer data to help you answer questions about specific patient subpopulations.
